Results 211 to 220 of about 19,414 (233)

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Cancer Cell, 2005
Jan Cools, Benjamin L Ebert, Gerlinde Wernig   +2 more
exaly  

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Lancet, The, 2005
Linda M Scott, Anthony R Green
exaly  

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Nature Reviews Drug Discovery, 2011
Hagop M Kantarjian
exaly  

Green synthesis of 3D tripyramid TiO2 architectures with assistance of aloe extracts for highly efficient photocatalytic degradation of antibiotic ciprofloxacin

Applied Catalysis B: Environmental, 2020
Mingshan Zhu
exaly  

EFFICAY STUDIES OF ALOE VERA GEL IN ATHEROSCLEROSIS

Atherosclerosis Supplements, 2008
P.P. Patel, S.A. Mengi
openaire   +1 more source

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

New England Journal of Medicine, 2015
Alessandro Maria Vannucchi, Martin Griesshammer, Tamás Masszi   +2 more
exaly  

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Roberto Marchioli, Giorgina Specchia, Valerio De Stefano   +2 more
exaly  

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

New England Journal of Medicine, 2004
Raffaele Landolfi, Roberto Marchioli, Heinz Gisslinger   +2 more
exaly  

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Lancet, The, 2005
Linda M Scott, George S Vassiliou, Anthony R Green   +2 more
exaly  

Studies on Rheological Properties of Aloe vera (Aloe barbadensis Miller) Gel

2009
S, Mohan Kumar, Ramachandra C T
openaire   +1 more source